Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hospitals, High-Volume × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sedentary Behavior 1 Motor Activity 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 2736 Cisplatin 2717 Carboplatin 2517 Radiotherapy 2420 Paclitaxel 2308 Gemcitabine 2166 pembrolizumab 2026 Docetaxel 1908 Bevacizumab 1861 Fluorouracil 1578 Capecitabine 1568 Oxaliplatin 1470 Dexamethasone 1359 Nivolumab 1330 Doxorubicin 1283 Rituximab 1274 Magnetic Resonance Spectroscopy 1170 Etoposide 1144 Irinotecan 1062 Leucovorin 1045 Drug Therapy 1020 Cytarabine 985 fludarabine 912 Pemetrexed 904 Specimen Handling 841 Lenalidomide 809 Vincristine 809 Cetuximab 804 Prednisone 802 Trastuzumab 800

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01435005 2018-01-30

BETA

AHS Cancer Control Alberta

Phase NA Completed

Breast Neoplasms, Motor Activity, Sedentary Behavior

Data powered by HemOnc (CC BY 4.0) Colophon ⚡